CD4 and COVID-19: We showed in this study that COVID-19 did not induce a concomitant activation of M. tuberculosis–specific CD4+ T cells, suggesting that acute SARS-CoV-2 infection may not immediately result in progression of latent M. tuberculosis to subclinical or active TB disease.